AIM ImmunoTech (AIM) Construction in Progress (2010 - 2014)
AIM ImmunoTech (AIM) recorded Construction in Progress of $7.34 million in Q4 2014, up 4.1% from $7.05 million a year earlier and up 0.9% from the prior quarter.
Powered by 
Analysis
AIM ImmunoTech (AIM) Construction in Progress (2010 - 2014) Analysis & Trends
Starting with Q4 2010, AIM ImmunoTech's Construction in Progress history includes 16 quarters.
- Annual Construction in Progress has increased for four straight years, with a four-year compound annual growth rate of 97.2% (FY2010 to FY2014).
- Across earlier years, Construction in Progress came in at $7.05 million in FY2013 (+7.1%), $6.58 million in FY2012 (+343.4%), $1.48 million in FY2011 (+206.0%) and $485,000 in FY2010.
- The Q4 2014 figure is the highest quarterly Construction in Progress in data going back to Q4 2010.
- On a year-over-year basis, Construction in Progress has increased for 11 consecutive quarters, with growth averaging 28.6% over the last eight quarters.
- Across the past five years, year-over-year growth in Construction in Progress ran from 1.7% in Q2 2014 to 442.0% in Q2 2012.
- Per Business Quant, the preceding three quarters came in at $7.27 million (Q3 2014), $7.19 million (Q2 2014) and $7.11 million (Q1 2014).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | AIM ImmunoTech | 3.08 Mn | -18.22 Mn | 21,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2014 | 7.34 Mn |
| Sep 30, 2014 | 7.27 Mn |
| Jun 30, 2014 | 7.19 Mn |
| Mar 31, 2014 | 7.11 Mn |
| Dec 31, 2013 | 7.05 Mn |
| Sep 30, 2013 | 6.97 Mn |
| Jun 30, 2013 | 7.07 Mn |
| Mar 31, 2013 | 6.81 Mn |
| Dec 31, 2012 | 6.58 Mn |
| Sep 30, 2012 | 5.79 Mn |
| Jun 30, 2012 | 4.35 Mn |
| Mar 31, 2012 | 3.03 Mn |
| Dec 31, 2011 | 1.48 Mn |
| Sep 30, 2011 | 1.21 Mn |
| Jun 30, 2011 | 802,000.00 |
| Dec 31, 2010 | 485,000.00 |
API Access
AIM ImmunoTech Construction in Progress API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=construction-in-progress&ticker=AIM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "construction-in-progress", "ticker": "AIM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=construction-in-progress&ticker=AIM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();